Literature DB >> 30097686

[Conservative treatment of atraumatic femoral head necrosis].

U Maus1, J Flechtenmacher2, K M Peters3.   

Abstract

BACKGROUND: Femoral head necrosis is a progressive disease that can progress within a relatively short time. Therefore, an early and clear diagnosis including stage classification and treatment is necessary to prevent or delay the onset of the femoral head and joint destruction. TREATMENT: In addition to the identification of possible risk factors and treatment, the question of the available treatment options arises. The present article deals with conservative treatment options and presents the published results in the sense of the currently available evidence and against the background of the S3 guideline on atraumatic femoral head necrosis. The results of physical therapy, drug therapy (iloprost and bisphosphonates ), electrotherapy, shockwave therapy, etc. are presented. In the early stages of femoral head necrosis with low expansion, alendronate gives positive results. Iloprost is also a successful conservative treatment option in the early stages of atraumatic femoral head necrosis (ARCO I and II). In stages ARCO III and IV, Ilomedin is no longer indicated. Anticoagulants, such as enoxaparin, have demonstrated an arthroprotective effect.

Entities:  

Keywords:  Bisphosphonates; Electric stimulation therapy; Femur head; High-energy shock waves; Iloprost

Mesh:

Year:  2018        PMID: 30097686     DOI: 10.1007/s00132-018-3616-6

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  41 in total

1.  Core decompression and conservative treatment for avascular necrosis of the femoral head: a meta-analysis.

Authors:  F P Castro; R L Barrack
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2000-03

Review 2.  [Pharmacotherapeutic aspects of femoral head necrosis].

Authors:  I H Tarner; R Dinser; U Müller-Ladner
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087

3.  The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study.

Authors:  Kuo-An Lai; Wun-Jer Shen; Chyun-Yu Yang; Chung-Jung Shao; Jui-Ting Hsu; Ruey-Mo Lin
Journal:  J Bone Joint Surg Am       Date:  2005-10       Impact factor: 5.284

4.  Effects of pulsed electromagnetic fields on Steinberg ratings of femoral head osteonecrosis.

Authors:  C A Bassett; M Schink-Ascani; S M Lewis
Journal:  Clin Orthop Relat Res       Date:  1989-09       Impact factor: 4.176

5.  Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant.

Authors:  K Nagasawa; Y Tada; S Koarada; H Tsukamoto; T Horiuchi; S Yoshizawa; K Murai; A Ueda; Y Haruta; A Ohta
Journal:  Lupus       Date:  2006       Impact factor: 2.911

6.  Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment.

Authors:  Lynne D Neumayr; Christine Aguilar; Ann N Earles; Harry E Jergesen; Charles M Haberkern; Bamidele F Kammen; Paul A Nancarrow; Eric Padua; Meredith Milet; Bernard N Stulberg; Roger A Williams; Eugene P Orringer; Nora Graber; Shanda M Robertson; Elliott P Vichinsky
Journal:  J Bone Joint Surg Am       Date:  2006-12       Impact factor: 5.284

7.  Are the results of multiple drilling and alendronate for osteonecrosis of the femoral head better than those of multiple drilling? A pilot study.

Authors:  Pengde Kang; Fuxing Pei; Bin Shen; Zongke Zhou; Jing Yang
Journal:  Joint Bone Spine       Date:  2011-07-13       Impact factor: 4.929

Review 8.  Non-traumatic avascular necrosis of the femoral head.

Authors:  M A Mont; D S Hungerford
Journal:  J Bone Joint Surg Am       Date:  1995-03       Impact factor: 5.284

9.  Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study.

Authors:  S Agarwala; D Jain; V R Joshi; A Sule
Journal:  Rheumatology (Oxford)       Date:  2004-11-30       Impact factor: 7.580

10.  Long-term Clinical Results after Iloprost Treatment for Bone Marrow Edema and Avascular Necrosis.

Authors:  Tim Claßen; Antonia Becker; Stefan Landgraeber; Marcel Haversath; Xinning Li; Christoph Zilkens; Rüdiger Krauspe; Marcus Jäger
Journal:  Orthop Rev (Pavia)       Date:  2016-03-31
View more
  1 in total

Review 1.  [Drug treatment of osteonecrosis].

Authors:  Andreas Roth; Uwe Maus
Journal:  Orthopadie (Heidelb)       Date:  2022-09-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.